Oncology outcomes
Does mixed DNA inside a head-and-neck tumor predict death?
Open access · cc by · source: Europe PMC
In 305 TCGA HNSCC patients, high intra-tumor MATH heterogeneity more than doubled the hazard of death (HR 2.2; 95% CI 1.4–3.3), even after HPV, TP53, grade, and N classification.
Study at a glance
- Design
- Cohort — Retrospective TCGA analysis of bulk-tumor WES MATH vs overall survival in HNSCC (diagnoses 1992–2011).
- N
- N=305 · 305 HNSCC patients from 14 institutions; 131 deaths (median time to death 14 months); living median follow-up 22 months.
- Population
- TCGA head and neck squamous cell carcinoma cases with clinical and whole-exome data (October 2013 freeze).
- Outcome
- Overall survival associated with high vs low mutant-allele tumor heterogeneity (MATH).
Structured fields used in claim comparison tables when every cited study has a complete layer.
Key findings
High MATH HR was 2.2 (univariate ~2.18). The association was not explained by age, HPV, grade, TP53, or N class, improved prognostication, and still split oral-cavity and laryngeal outcomes after staging. Chemoradiotherapy patients showed a particularly large HR (5.2).
Methodology
Calculated MATH from bulk-tumor whole-exome sequencing for 305 HNSCC cases from 14 institutions and related high vs low MATH to overall survival with Cox models, including multivariate adjustment for standard clinical/molecular factors.
Limitations
Retrospective multi-site TCGA data were not collected to study MATH; prospective, homogeneously treated series (especially HPV+ oropharynx) are still required before clinical use.
How this study connects
Role on claims
Each row is a claim on a concept or method page where this paper supports, challenges, or qualifies the statement. Roles are hand-checked — not a model guess.
Not yet placed on a claim. This paper has study layers, but no concept page yet cites it as support, challenge, or qualifier.
Related papers in this topic
Same topic cluster — not a recommendation engine.
- miR-122 exosomes from fat stem cells sensitize HCC models to chemo
- A 22-gene classifier flags early metastasis after prostatectomy
- HDAC2 IHC tracks shorter PSA relapse in prostate cancer
- Does ovarian-cancer clone diversity predict death?
- Five integrated genomic subgroups track prostate-cancer relapse risk